CFL1 and Alzheimer disease: Quantification of these four proteins showed no significant differences between AD and the control group: Iba1: control = 0.34% (IQR: 0.08–0.63%) vs AD = 0.29%(IQR: 0.13–0.68%), P = 0.788; CFL1: control = 0.15% (IQR: 0.03–0.038%) vs AD = 0.08% (IQR: 0.04–0.022%), P = 0.314; P2RY12: control = 0.00% (IQR: 0.00–0.55%) vs AD = 0.09% (IQR: 0.00–1.09%), P = 0.290; CORO1A: control = 0.21% (IQR: 0.10–0.52%) vs AD = 0.17% (IQR: 0.03–0.33%), P = 0.406.